Investments and investor services
Oil majors drag London lower despite upbeat Greek news
European indices climb after Eurogroup approves Greek bailout
Company
e-Therapeutics PLC
LON:ETX
e-Therapeutics PLC is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines. The company has developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. e-Therapeutics' multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.
153 stories · page 8 of 8
Builders and building materials
FTSE 100 ends flat as housebuilders dominate news
UK stocks managed to pare most of its losses on the day...
Cancer drug firms to cash in on $9bn immunotherapy market
Trials have shown that immunotherapy may revolutionise cancer treatment
e-Therapeutics bullish on discovery platform
"With the progress we are making both in the clinical programmes and in discovery, we expect another exciting year,"